Randomized Trial of Ibrutinib Versus Ibrutinib Plus Rituximab (Ib+R) in Patients with Chronic Lymphocytic Leukemia (CLL)Jan A. Burger, Michael J. Keating, Alessandra Ferrajoli et al.|Blood|2017Cited by 15